info@clinicalcasereportsjournal.com

David Andrew Winton Collier

David Andrew Winton Collier

David Andrew Winton Collier

MD, PhD Glasgow University, Department of Diabetes United Kingdom

BIOGRAPHY 3 PUBLICATIONS 122

We cordially invite you to join our board.

Your valuable suggestions improve our journal quality. We welcome you to be part of our board members.

Join Board

David Andrew Winton Collier holds the position of Professor of Diabetes Care at Glasgow University. He is a Consultant in General Medicine / Diabetology and Endocrinology at Ayr Hospital, Scotland. He is a fellow of Royal College of Physicians of Edinburgh and also of the Royal College of Physicians and Surgeons of Glasgow. 

David Andrew Winton Collier is Regional Adviser for Strathckyde Region for the Royal College of Physicians of Edinburgh and also is a member of Council and Fellowship Committee of Education and Strategy group of Royal College. Apart from his clinical work, he is presently supervising four PhD students, M.Sc. Research from Stirling University Psychology Department and Glasgow Caledonian University. 

David Andrew Winton Collier is the member of executive committee of the Scottish Diabetes Research Network (SDRN) and also a member of a Scottish Education Action Group Committee. Throughout his carrier he has been intimately involved in teaching and has been a lead examiner for PACES examination. He has more than 100 publications in international peer reviewed journals and has written multiple chapters in text books.

  • Collier A, Ashworth B.  Multiple plasmacytoma presenting as raised intracranial pressure.J of Neurol, Neurosurg and Psych. 1987;50:495-496.
  • Glass EJ, Stewart J, Matthews DM, Collier A, Clarke BF, Weir DM. Impairment of human monocyte “lectin-like” receptor activity in insulin-dependent diabetics. Diabetologia. 1987;228-231.
  • Collier A, Tymkewycz PM, Matthews DM, Jones RL, Clarke BF.  Increased platelet sensitivity to inhibiting prostaglandins and thromboxane production in insulin-dependent diabetics with short-term improvement of glycaemic control. Diabetes Res. 1987;5:79-82.
  • Matthews DM, Wathen CG, Bell D, Collier A, Roulston JC, Clarke BF, Muir AL.  The use of Captopril as an antihypertensive agent in non-insulin dependent diabetes. J Hum Hypertension. 1987;1:19-23.
  • Collier A, Matthews DM, Young RJ, Clarke BF.  Atrial fibrillation precipitated by hypoglycaemia:  2 case reports.  Postgrad Med J. 1987;63:395-897.
  • Blackwell CC, James VS, Weir DM, Gemmill JD, Patrick AW, Collier A, Clarke BF. Secretor state of patients with insulin and non-insulin dependent diabetes. Br Med J. 1987;1024-1025.
  • Collier A, Steedman DJ, Patrick AW, Nimmo GR, Matthews DM, Macintyre CCA, Little K, Clarke BF.  Comparison of intravenous glucagon and dextrose in the treatment of severe hypoglycaemia in an accident and emergency department. Diabetes Care .1987;10:712-715.
  • Patrick AW, Collier A, Matthews DM, Macintyre CCA, Clarke BF.  Time interval between insulin injection and breakfast and postprandial glycaemic control - a comparison between human and porcine insulin.  Diabetic Med 1988;5: 32-35.
  • Buchanan D, Collier A, Rodrigues E, Miller AM, Gray RD, Clarke BF.  Evaluation of the effect of an alpha-glucosidase inhibitor (Acarbose) on diabetic control in non-obese type 2 diabetics.  Eur J Clin Pharm. 1988;34:51-53.
  • Bell D, Collier A, Matthews DM, Cooksey EJ, McHardy GJR, Clarke BF.  Reduced lung volumes in insulin-dependent diabetes:  a connective tissue defect? Diabetes. 1988;37:829-831.
  • Bell D, Collier A, Nicoll JJ, Jackson M, Clarke BF, Muir AL.  Reduced  vascular compliance and increased capillary permeability in young male insulin dependent diabetics.Diabetic Med 1988;5:454-458.
  • Collier A, Reid W, McInnes A, Cull RE, Ewing DJ, Clarke BF.  Somatosensory and visual evoked potentials in insulin-dependent diabetics with mild peripheral neuropathy.Diab Res Clin Prac. 1988;5:171-175.
  • Collier A, Blackwell CC, Patrick AW, James V, Weir D, Toft AD.  Increased incidence of non-secretors in patients with Graves’ disease - evidence for an infective aetiology? Brit Med J. 1988;296:1162.
  • Patrick AW, Collier A.  An infectious aetiology of insulin-dependent diabetes mellitus? - role of the secretor state, in Blood groups, secretor status and susceptibility to disease states. FEMS Microbiol Immunol. 1989;47: 411-416.
  • Patrick AW, Fisher BM, Collier A, Howie AF, Frier BM.  Liver function tests after hypoglycaemia in insulin-dependent diabetic patients. Pract Diab. 1988;5:114-115.
  • Kellett HA, Collier A, Taylor R, Sawers JSA, Doig A, Baird DT, Clarke BF. Hyperandrogenism, insulin resistance, acanthosis nigricans and SLE associated with insulin receptor antibodies. Metabolism. 1988;37:656-659.
  • Collier A, Jackson M, Dawkes RM, Bell D, Clarke BF.  Free radical activity detected by diene conjugates in insulin-dependent diabetic patients.  Diabetic Med. 1988;5:747-749.
  • Priestley GC, Collier A, Matthews DM, Clarke BF.  Increased urinary excretion of glycosaminoglycans in male diabetic patients with cheiroarthropathy. Br J Rheumatol. 1988;462-464.
  • Tibi L, Collier A, Patrick AW, Clarke BF, Smith A.  Plasma alkaline phosphatase isoenzymes in diabetes mellitus. Clin Chim Acta. 1988;177:147-156.
  • Howie AF, Patrick AW, Fisher BM, Collier A, Frier BM, Beckett GJ.  Plasma hepatic glutathione S-transferase concentrations after insulin-induced hypoglycaemia in normal subjects and diabetic patients. Diabetic Med. 1989;6:224-227.
  • Eadington D, Patrick AW, Collier A, Frier BM.  Limited joint mobility, Dupuytren’s contracture and retinopathy in Type 1 diabetes:  association with cigarettes smoking.Diabetic Med. 1989;6:152-157.
  • Collier A, Patrick AW, Bell D, Matthews DM, Macintyre CM, Ewing DJ, Clarke BF.Relationship of skin thickness to duration of diabetes, glycaemic control and diabetic complications in male insulin-dependent diabetic patients. Diabetes Care. 1989;12:309-312.
  • Bell D, Collier A.  Transfer factor for carbon monoxide in patients with diabetes with and without microangiopathy.  Thorax. 1989;44:446.
  • Patrick AW, Collier A, Clarke BF.  Simultaneous onset of Type 1 diabetes mellitus in three brothers - strong evidence for an environmental factor in the aetiology of the disease? Pract Diab. 1989;6:122-123.
  • Jenkins DAS, Craig K, Collier A, Watson ML, Clarke BF.  Evidence against a role of prostaglandins in sustaining renal hyperfiltration in Type 1 diabetes mellitus. Diabetic Med. 1989;6:502-505.
  • Collier A, Jackson M, Bell D, Patrick AW, Matthews DM, Young RJ, Clarke BF, Dawes J. Increased neutrophil elastase activity in insulin-dependent diabetes mellitus. Diabetes Res. 1989;9:117-120.
  • Collier A, Matthews DM, Cumming AD, Clarke BF.  Urinary kallikrein excretion in insulin-dependent diabetic patients. Diab Nut Metab. 1989;15:420-425.
  • Armstrong RA, Lawrence RA, Jones RL, Wilson NH, Collier A.  Functional and ligand binding studies suggest heterogenecity of prostacyclin receptors. Br J Pharmacol. 1989;97:657-668.
  • Patrick AW, Jeffrey RF, Collier A, Clarke BF, Lee MR.  Urinary sodium-dopamine relationship in insulin-dependent diabetes mellitus. Diabetic Med. 1990;7:53-56.
  • Blackwell CC, Weir DM, Patrick AW, Collier A, Clarke BF.  Secretor state and complement levels (C3 and C4) in insulin-dependent diabetes mellitus. Diabetes Res. 1988;9:117-119.
  • Capewell S, Collier A, Matthews DM, Hajducka C, Collier R, Clarke BF, Muir AL.Felodopine in patients with non-insulin dependent diabetes mellitus and hypertension. Diabetic Med. 1989;6:809-812.
  • Collier A, Wilson R, Bradley H, Thomson JA, Small M. Free radical activity in non-insulin dependent diabetes. Diabetic Med. 1990;7: 27-30.
  • Collier A, Watson HHK, Patrick AW, Ludlam CA, Clarke BF.  Effect of metformin and gliclazide on platelet density and aggregability in recently diagnosed Type 2 (non-insulin-dependent) diabetic patients. Diabete Metab. 1989;15:1420-1425.
  • Collier A, Patrick AW, Hepburn DA, Bell D, Jackson M, Dawes J, Frier BM. Leucocyte mobilisation and release of neutrophil elastase following acute insulin-induced hypoglycaemia in normal humans. Diabetic Med. 1990;7:506-509.
  • Patrick AW, Collier A, Hepburn DA, Steadman DJ, Clarke BF, Robertson C. Comparison of im glucagon and iv dextrose in the treatment of hypoglycaemic coma in an accident and emergency department.  Archiv Acc Emerg Med. 1990;7:73-77.
  • Jenkins DAS, Craig K, Collier A, Watson ML, Clarke BF.  Blood glucose control determines the renal haemodynamic response to angiotensin converting enzyme inhibition in Type 1 diabetes. Diabetic Med. 1990;7:252-257.
  • Blackwell CC, Aly FZM, James VS, Weir DM, Collier A, Patrick AW, Cumming G, Wray D, Clarke BF.  Blood group, secretor status and oral carriage of yeasts among patients with diabetes mellitus. Diabetes Res 1989;12:101-104.
  • Jeffrey RF, Capewell S, Brown J, Collier A, Hajducka C, Lee MR.  Effects of felodipine on atrial natruiretic  factor in hypertensive non-insulin dependent diabetes mellitus. Brit J Clin Pharmacol. 1990;30:481-484.
  • Collier A, Small M.  The polyol pathway; its possible role in the development of diabetic complications. Br J Hosp Med. 1991;45:38-40.
  • Stewart J, Collier A, Patrick AW, Clarke BF, Weir DM.  Alterations in monocyte receptor function in Type 1 (insulin-dependent) diabetic patients with ketoacidosis. Diabetic Med. 1991;8:213-216.
  • Jackson M, Collier A, Nicoll JJ, Dawes J, Muir AL, Clarke BF, Bell D.  Neutrophil count and activation in vascular disease. Scot Med J. 1992;37:41-43.
  • Collier A, Leach JP, McLellan A, Jardine A, Morton JJ, Small M. Increased plasma endothelin levels in microalbuminuric insulin-dependent diabetic patients. Diabetes Care. 1992;1038-1040.
  • Collier A, Rumley A, Rumley AG, Paterson JR, Leach JP, Lowe GDO, Small M.  Free radical activity and hemostatic measures in non-insulin-dependent diabetic patients with and without microalbuminuria. Diabetes. 1992;40:909-913.
  • Ingram MC, Wallace M, Collier A, Fraser R, Connell JMC.  Sodium status, cortico-steroid metabolism and blood pressure in normal human subjects and in a patient with abnormal salt appetite.  Clin. Exp. Phys. Pharm. 1996;23:375-378.
  • Ghosh S, Collier A. Inhaled Insulins. Postgrad Med J. 2007;83:178-181.
  • Ryan D, Ghosh S, Collier A. Day surgery & obesity. B J of Anaesthesia. 2007;99:449.
  • Ghosh S, McCann V, Bartle L, Collier A, Malik I. Allergy to insulin detemir. Diab Med. 2007;24:1307-1308.
  • Elhadd TA, Ghosh S, Malik IA, Collier A. Plantar fibromatosis and Dupuytren’s disease: an association to remember in patients with diabetes. Diab Med. 2007;24:130.
  • Ghosh S, Roychoudhury A, Collier A, Malik I, S. Sarkar S, J. Pal J. Radioiodine therapy in patients with Graves' disease and toxic multinodular goiter in a Scottish population - Comparision of efficacy of two different doses. Horm Res. 2007;68.
  • Sarkar S, Ghosh S, Collier A, Ghosh S K. Role of transcranial doppler ultrasonography in Stroke. Postgrad. Med. J. 2007;83;683-689.
  • Shah IM, Ghosh SK, Collier A. Stroke presentation in type 2 diabetes and the metabolic syndrome. Diab Res Clin Prac. 2008;79:1-4.
  • Ghosh S, Collier A, Milne A, Simpson C, Malik IA. Diabetic Mastopathy. Pract Diab Int. 2008;25:10–11.
  • Ghosh S. Shetty S, Malik IA, Collier A. Cheiroarthropathy in pre-diabetes Intern J of Rheum Dis. 2008;11:81–82.
  • Collier A, Ghosh S, Dowie A, Walsh K, O’Leary C. HIV testing in dementia: clinical, ethical, and patient safety implications. Brit J of Hosp Med. 2008;69:500–503.
  • Ghosh S, Howlett M, Boag D, Malik IA, Collier A. Interference in free thyroxine immunoassay. Eur.J.Intern.Med. 2008;19:221-222.
  • Ghosh S, Collier A, Elhadd TA, Malik IA. Incretin based therapies for type 2 diabetes mellitus. J of Indian Med Assoc. 2008;106:373-383.
  • Ghosh S, Ghosh AK, Collier A. A 74 year old woman with a 1 month history of itching and skin rash. Ann of Saudi Med. 2009;29:234-235.
  • Collier  A, Ghosh S, D. F. Davidson DF, Kilpatrick ES. HbA1c: ‘The old order changeth’. Diab Med. 2009;26:573-576.
  • Ghosh S, Bal AM, Malik IA, Collier A. Fatal Morganella morganii bacteraemia in a diabetic patient with gas gangrene. J of Med Microbiology. 2009;58:965-968.
  • Grant S, Dearing J, Ghosh S, Collier A, Bal AM. Necrotizing myositis of the deltoid following intramuscular injection of anabolic steroid. Int J Infect Dis. 2010;14:823-824.
  • Ghosh S, Collier A, Elhadd TA, Malik IA. Retinopathy in prediabetes. B J of   Diab & Vasc Dis. 2010;10:155-156.
  • Ghosh S, Collier A, Hair M, Malik IA, Elhadd TA. Metabolic syndrome in type 1 diabetes. Int J of Diab Mell. 2010;2:38–42.
  • Collier A, Ghosh S, Hair M, Malik IM, Mcgarvie J. Comparison of two fixed doses of radio-iodine therapy (370 vs. 555 MBq) in patients with Graves’ disease. Hormones. 2009;8:273-278.
  • Bal AM, Collier A, Dowie A, Ghosh S. Policy needs to be revisited. BMJ. 2010;341.
  • Elhadd TA, Ghosh S, Teoh WL, Trevethick KA, Hanzely Z, Dunn LT, Malik IA, Collier A.  A patient with thyrotropinoma co-secreting Growth Hormone and Follicle-Stimulating Hormone with low alpha-glycoprotein: A new subentity? Thyroid. 2009;19:893-898.
  • Malik I, Ghosh S, Nutt C, Macdonald A, Bal AM, Collier A. Gemella haemolysans bacteraemia in a patient with solitary liver abscess. J Micro, Immunol Inf. 2010;43:438-441.
  • Ghosh S, Collier A, Storey C, Clerk D, Malik I.  Social deprivation and primary hyperparathyroidism. Endo Prac. 2010;16:982-985.
  • Collier A, Ghosh S, McGlynn B, Hollins G. Prostate Cancer, Androgen Deprivation Therapy, Obesity, the Metabolic Syndrome, Type 2 Diabetes, and Cardiovascular Disease: A Review. Amer J Clin Onc. 2012;35:504-509.
  • Collier A, Rennie N, Ghosh S, Davidson F, Williamson S. Growth retardation. J Paed Child Health. 2012;48:537-539.
  • Chan HWE, Ashan B, Jayasekera P, Collier A, Ghosh S. A new class of drug for the management of type 2 diabetes: Sodium glucose co-transporter inhibitors: ‘Glucuretics’. Diab Metab Synd: Clin Res & Rev. 2012;6:224-228.
  • Collier A. Bariatric surgery and diabetes. Ind J Endo Metab. 2012;16(Suppl 2):S230–S232.
  • Collier A. Thyrotoxicosis and radioiodine therapy: Does the dose matter?  Ind J Endo Metab. 2012;16:147-149.
  • Collier A, McLaren J,Godwin J, Bal A. Is Clostridium difficile associated with the ‘4C’ antibiotics? A retrospective observational study in diabetic foot ulcer patients. Int J Clin Prac. 2014;68:628–632.
  • Collier A, Ghosh S, Hair M, Waugh N. Gender differences and patterns of cardiovascular risk factors in type 1 and type 2 diabetes: a population based analysis from a Scottish region. Diabetic Med. 2015;32:42-46.
  • Collier A, Ghosh S, Hair M, Waugh N. Socio-economic variations in type 1 and 2 diabetes: a population based analysis from a Scottish region. Diabetes & Metabolism. 2015;41:145–151.
  • Collier A, Watts M, Ghosh S, Rice P, Dewhurst N. Alcohol dependence and driving: knowledge of DVLA regulations. Psychiatric Bulletin; published ahead of print October 9, 2014 doi:10.1192/pb.bp.113.045963.
  • Collier A, Stirling A, Cameron L, Hair M, Crosbie D. Gout and diabetes: a common combination. Postgrad Med J. 2016 Jul; 92(1089): 372-8. doi: 10.1136/postgradmedj-2015-133691. Epub 2016 May 10.
  • Smith K, Collier A, Townsend EM, O’Donnell LE, Bal AM, Butcher J, Mackay WJ, Ramage G, Williams C. One step closer to understanding the role of bacteria in diabetic foot ulcers: characterising the microbiome of ulcers. BMC Microbiology 2016; 16:54 DOI 10.1186/s12866-016-0665-z.
  • Ajjan RA, Abougila K, Bellary S, Collier A, Franke B, Jude EB, Rayman G, Robinson A, Singh BM. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients. Diabetes & Vascular Disease Research. 2016;13:211–219.
  • Jack L, Bal AM, Harte S, Collier A. International guidelines: the need to standardize the management of candidaemia. Infectious Diseases. 2016;48:11-12.
  • Lavery CA, Kurowska-Stolarska M, Holmes WM, Donnelly I, Carslake M, Collier A, Baker AH, Miller AM. miR-34a-/- mice are susceptible to diet-induced obesity. Obesity. 2016;24:1741-1751.
  • Collier A, Abraham CE, Armstrong J, Godwin J, Monteath K, Lindsay R.Reported prevalence of Gestational Diabetes in Scotland: the relationship to obesity, age, socioeconomic status, smoking and macrosomia and how many are we missing? J Diabetes Investig. 2016 Jul 10. doi: 10.1111/jdi.12552. [Epub ahead of print].
  • Telfer S, Collier A, Cavanagh P, Woodburn J. Virtually optimized insoles for offloading the diabetic foot: a randomized crossover study. Journal of Biomechanics. 2017;60:157-161.
  • Collier A, Kessavalou K, Sit LE, Hair M, Cameron L, Abdeen A. Anti-psychotic medication and the pattern of cardiovascular risk factors: a population based study (The Ayrshire Diabetes Follow-Up Cohort (ADOC) Study). J Addict Res Ther. 2017;8:343-348.
  • Courtney L, Collier A. Does dietetic input improve glycaemic control and weight loss in patients with type 2 diabetes on GLP-1 analogues? Practical Diabetes (in press).
  • Collier A, Connelly P, Hair M, Cameron L, Ghosh S, Waugh N. Mortality risk is still increased in people with type 1 diabetes: a population-based cohort study (The Ayrshire Diabetes follow-up Cohort (ADOC) study). Diabetes, Obesity and Metabolism 2018 Aug;20:1965-1971. doi: 10.1111/dom.13334. Epub 2018 May 29.
  • Collier A, Hair M, Cameron L, Ghosh S, Walters M, Waugh N. Mortality risk is still increased in people with type 2 diabetes: a population-based cohort study (The Ayrshire Diabetes fOllow-up Cohort (ADOC) study). (submitted for publication).
  • Mullen C, Collier A, Jack L, Smyth J, Bal AM. Diabetes, malignancy and age as predictors of Candida glabrata bloodstream infection: a re-evaluation of the risk factor. Journal de Mycologie Médicales (in press).
  • Bermingham ML, Colombo M, McGurnaghan SJ, Blackbourn LAK, Vuckovic F, Bakovic MP,  Trbojevic-Akmacic I, Lauc G, Agakov F, Agakova AS, Hayward C, Klaric L, Palmer CNA, Petrie JR, Chalmers J, Collier A, Green F, Lindsay RS, Macrury S McKnight JA Patrick AW, Thekkepat S, Gornik O, McKeigue PM, Colhoun HM,  on behalf of the SDRN Type 1 Bioresource Investigators. N-Glycan Profile and Kidney Disease in Type 1 Diabetes. Diabetes Care 2018 Jan; 41(1): 79-87. https://doi.org/10.2337/dc17-1042.
  • Bisambar C, Collier A, Duthie F, Meney C. Non-functional duodenal neuroendocrine carcinoma: a rare cause of diabetes mellitus. Endocrinology, Diabetes & Metabolism (in press).
  • Paing AC, McMillan KA, Kirk AF, Collier A, Hewitt A, Chastin SFM. The associations of sedentary time and breaks in sedentary time with 24-hour glycaemic control in type 2 diabetes. Preventive Medicine Reports 2018;12:94-100.
  • Paing A C, McMillan K A, Kirk A F, Collier A, Hewitt A, Chastin S F M. Dose–response between frequency of interruption of sedentary time and fasting glucose, the dawn phenomenon and night-time glucose in Type 2 diabetes. Diabetic Medicine. 2018; ISSN 0742-3071.DOI: 10.1111/dme.13829.
  • Ragab MEZ, Omar SS, Collier A, El-Wafa RAHA, Gomaa N. The effect of continuous high versus low dose oral isotretinoin regimens on dermcidin expression in patients with moderate to severe acne vulgaris. Dermatologic Therapy. 2018; e12715.
  • Paing AC, McMillan KA, Kirk AF, Collier A, Hewitt A, Chastin SFM. Dose-response between frequency of breaks in sedentary time and glucose control in type 2 diabetes: A proof of concept study. J Science and Med Sport.
  • McKeigue PM, Spiliopoulou A, McGurnaghan S, Colombo M, Blackbourn L, McDonald TJ, et al. Persistent C-peptide secretion in Type 1 diabetes and its relationship to the 1 genetic architecture of diabetes.
  • Paing AC, Kirk AF, Collier A, Kubiak T, Chastin SFM: Are glucose profiles well-controlled within the targets recommended by the International Diabetes Federation in type 2 diabetes? A meta-analysis of results from continuous glucose monitoring based studies. Diabetes Research and Clinical Practice: International Diabetes Federation 2018;146:289-299.
  • Yazdani-Ibn-Taz MK, Han MM, Jonuscheit S, Collier A, Nally JE, Hagan S.  Patient-reported severity of dry eye and quality of life in diabetes. Clin Ophthalmol. 2019; 25:13:217-224. doi: 10.2147/OPTH.S184173. eCollection 2019.
  • Nsoh M, Mankollo BOY, Ebongue M, Cyprien KN, Likeng JLN, Islam SMS, Collier A, Tsoka-Gwegweni JM, Cumber SN. Acute respiratory infection related to air pollution in Bamenda, North West Region of Cameroon. Pan African Med J. 2019;32:99-104.
  • Paing AC, McMillan KA, Kirk AF, Collier A, Hewitt A, Owen N, Chastin SFM. Diurnal patterns of objectively measured sedentary time and breaks in sedentary time are associated with glucose control in Type 2 diabetes. Diab Med (in press).
  • Paing AC, McMillan KA, Kirk AF, Collier A, Hewitt A, Chastin SFM. Impact of free-living pattern of sedentary behaviour on intra-day glucose regulation in type 2 diabetes. Eur J Appl Physiol 2019.

PRINCIPAL or CO-INVESTIGATOR FOR THE FOLLOWING STUDIES (Post 2007): 

ICH/GCP: re-newed – 24th December 2018:

  • Liraglutide Effect and Action in Diabetes (LEAD-5) Trial.
  • Treating to Target in Type 2 Diabetes (4T Study). 
  • Inhaled pre-prandial human insulin with the AERx® iDMS versus s.c. insulin aspart in type 2 diabetes. 
  • Insulin Titration- Gaining an understanding of the burden of Type 2 diabetes in Europe (INSTIGATE) Study. Lantus_L_03666: SOLOSTAR European Prospective Survey.
  • Predictable Results and Experience in Diabetes Through Intensification and Control to Target: An International Variability Evaluation: The PREDICTIVE Study. 
  • Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events (NAVIGATOR Study). 
  • GLP-1 agonist AVE0010 in patients with type 2 diabetes mellitus in Glycemic cOntrol and sAfety evaluation, on top of basal insulin (GETGOAL-L). 
  • Levemir in Later Life (3L) study.
  • Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison (COMBO study).
  • A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus (Alecardio, Roche).
  • Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes (Novo Nordisk).
  • Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home Study (IHUT, Abbott Diabetes Care), SIGN (Abott Diabetes Care).
  • Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND, Lilly).
  • Monotherapy Study of MP-513 in Patients With Type 2 Diabetes (Mitsubishi).
  • LanScape (Sanofi).
  • Post-PROactive: Observational follow up (Takeda).
  • Type 1 Bioresource (SDRN).

Are you interested in submitting your research paper?

Thank you for choosing us. We recommend you to go through our guidelines before submitting the paper.

Submit Manuscript
Logo

Clinical Case Reports Journal is the state-of-the-art platform to showcase medical journals across scientific community and a one-stop solution for publishing the manuscripts of varied medical specialities.

Main Links

Useful Links

Our Contacts

CLINICAL CASE REPORTS JOURNAL,
C/O Infact Publications LLC,
16192 Coastal Highway,
Lewes, Delaware 19958
USA

info@clinicalcasereportsjournal.com
https://clinicalcasereportsjournal.com